HomeCONGRESS

CONGRESS

AHA 2019 | COLCOT: Colchicine and the Return of the Anti-Inflammatory Theory

Low-dose colchicine seems to reduce the risk for new cardiovascular events in patients with a history of...

AHA 2019 | TWILIGHT: Discontinue Aspirin after Acute Coronary Syndrome

This study findings confirm less bleeding at no extra cost of thrombotic events when aspirin is discontinued...

AHA 2019 | RECOVERY: Early Surgery in Asymptomatic Severe Aortic Stenosis

This small randomized study heated the debate about when to intervene aortic stenosis (AS). Putting off surgical...

AHA 2019 | GALILEO-4D: Rivaroxaban in the Prevention of Post TAVR Valve Thickening and Thrombosis

This sub study of the GALILEO specifically looked at valve thickening and reduced leaflet motion after TAVR...

AHA 2019 | ISCHEMIA: The Invasive Approach (PCI or Surgery) Results Similar to Optimal Medical Treatment

After a several year follow up, the International Study of Comparative Health Effectiveness with Medical and Invasive...

AHA 2019

Here you will find the highlights of the AHA 2019 Scientific Sessions, held on November 16th to...

Regional Course of Interventionism for the Clinical Cardiologist | with SOLACI’s Support

On November 30, 2019, the “I Regional Course of Interventionism for the Clinical Cardiologist” will take place...

SOLACI Symposium at SOCHICAR 2019

The Latin American Society of Interventional Cardiology is proud to present together with the Chilean Society of Cardiology (SOCHICAR) a...